Cargando…

Cohort profile: Anhui Maternal–Child Health Study in China

PURPOSE: The Anhui Maternal–Child Health Study (AMCHS) aims to examine determinants of reproduction, pregnancy and postpartum maternal and child health outcomes in Chinese women who received assisted reproductive technology (ART). STUDY DESIGN AND PARTICIPANTS: AMCHS is an ongoing cohort study start...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Jiaqian, Cao, Yunxia, Liang, Chunmei, Peng, Xiaoqing, Xu, Xiaofeng, Zhou, Weiju, Khutan, Ranjit, Tao, Fang-Biao, Chen, Ruoling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240940/
https://www.ncbi.nlm.nih.gov/pubmed/35768099
http://dx.doi.org/10.1136/bmjopen-2021-060091
_version_ 1784737678454947840
author Yin, Jiaqian
Cao, Yunxia
Liang, Chunmei
Peng, Xiaoqing
Xu, Xiaofeng
Zhou, Weiju
Khutan, Ranjit
Tao, Fang-Biao
Chen, Ruoling
author_facet Yin, Jiaqian
Cao, Yunxia
Liang, Chunmei
Peng, Xiaoqing
Xu, Xiaofeng
Zhou, Weiju
Khutan, Ranjit
Tao, Fang-Biao
Chen, Ruoling
author_sort Yin, Jiaqian
collection PubMed
description PURPOSE: The Anhui Maternal–Child Health Study (AMCHS) aims to examine determinants of reproduction, pregnancy and postpartum maternal and child health outcomes in Chinese women who received assisted reproductive technology (ART). STUDY DESIGN AND PARTICIPANTS: AMCHS is an ongoing cohort study starting from May 2017. AMCHS recruits participants from all couples who sought ART treatment in the First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China. The participants are interviewed to document baseline sociodemography, lifestyles, dietary intake and environmental exposure. Their clinical characteristics are obtained from hospital records. Samples of blood, follicular fluid and semen are collected at the clinic. Participants receive a standard long pituitary downregulation or a short protocol with an antagonist for the treatment. They are followed up from preconception to delivery, or discontinuation of ART treatment. Details of their children’s health are documented through a questionnaire focusing on developmental status and anthropometry measurement. FINDINGS TO DATE: Until April 2021, AMCHS had recruited 2042 couples in the study. 111 women withdrew from the study and 19 failed to retrieve oocytes. Among the 1475 confirmed pregnancies, 146 had miscarriages or terminated their pregnancies, 9 had stillbirths and 263 were ongoing pregnancies. The implantation failure increased with maternal age; adjusted OR was 1.43 (95% CI 1.16 to 1.77) in the age of 31–35 years, 1.97 (95% CI 1.46 to 2.66) in 35–39 years and 6.52 (95% CI 3.35 to 12.68) in ≥40 years compared with those aged 20–30 years. Among the 1057 couples with successful ART who were followed up for delivering babies, 576 had their children examined at age 30–42 days, 459 at 6 months and 375 at 12 months. FUTURE PLANS: The AMCHS will identify comprehensive risk factors for poor ART outcomes and explore potential interaction effects of multiple factors including sociopsychological aspects of environmental exposure, dietary intake and genetics on maternal and child health.
format Online
Article
Text
id pubmed-9240940
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-92409402022-07-20 Cohort profile: Anhui Maternal–Child Health Study in China Yin, Jiaqian Cao, Yunxia Liang, Chunmei Peng, Xiaoqing Xu, Xiaofeng Zhou, Weiju Khutan, Ranjit Tao, Fang-Biao Chen, Ruoling BMJ Open Reproductive Medicine PURPOSE: The Anhui Maternal–Child Health Study (AMCHS) aims to examine determinants of reproduction, pregnancy and postpartum maternal and child health outcomes in Chinese women who received assisted reproductive technology (ART). STUDY DESIGN AND PARTICIPANTS: AMCHS is an ongoing cohort study starting from May 2017. AMCHS recruits participants from all couples who sought ART treatment in the First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China. The participants are interviewed to document baseline sociodemography, lifestyles, dietary intake and environmental exposure. Their clinical characteristics are obtained from hospital records. Samples of blood, follicular fluid and semen are collected at the clinic. Participants receive a standard long pituitary downregulation or a short protocol with an antagonist for the treatment. They are followed up from preconception to delivery, or discontinuation of ART treatment. Details of their children’s health are documented through a questionnaire focusing on developmental status and anthropometry measurement. FINDINGS TO DATE: Until April 2021, AMCHS had recruited 2042 couples in the study. 111 women withdrew from the study and 19 failed to retrieve oocytes. Among the 1475 confirmed pregnancies, 146 had miscarriages or terminated their pregnancies, 9 had stillbirths and 263 were ongoing pregnancies. The implantation failure increased with maternal age; adjusted OR was 1.43 (95% CI 1.16 to 1.77) in the age of 31–35 years, 1.97 (95% CI 1.46 to 2.66) in 35–39 years and 6.52 (95% CI 3.35 to 12.68) in ≥40 years compared with those aged 20–30 years. Among the 1057 couples with successful ART who were followed up for delivering babies, 576 had their children examined at age 30–42 days, 459 at 6 months and 375 at 12 months. FUTURE PLANS: The AMCHS will identify comprehensive risk factors for poor ART outcomes and explore potential interaction effects of multiple factors including sociopsychological aspects of environmental exposure, dietary intake and genetics on maternal and child health. BMJ Publishing Group 2022-06-27 /pmc/articles/PMC9240940/ /pubmed/35768099 http://dx.doi.org/10.1136/bmjopen-2021-060091 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Reproductive Medicine
Yin, Jiaqian
Cao, Yunxia
Liang, Chunmei
Peng, Xiaoqing
Xu, Xiaofeng
Zhou, Weiju
Khutan, Ranjit
Tao, Fang-Biao
Chen, Ruoling
Cohort profile: Anhui Maternal–Child Health Study in China
title Cohort profile: Anhui Maternal–Child Health Study in China
title_full Cohort profile: Anhui Maternal–Child Health Study in China
title_fullStr Cohort profile: Anhui Maternal–Child Health Study in China
title_full_unstemmed Cohort profile: Anhui Maternal–Child Health Study in China
title_short Cohort profile: Anhui Maternal–Child Health Study in China
title_sort cohort profile: anhui maternal–child health study in china
topic Reproductive Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240940/
https://www.ncbi.nlm.nih.gov/pubmed/35768099
http://dx.doi.org/10.1136/bmjopen-2021-060091
work_keys_str_mv AT yinjiaqian cohortprofileanhuimaternalchildhealthstudyinchina
AT caoyunxia cohortprofileanhuimaternalchildhealthstudyinchina
AT liangchunmei cohortprofileanhuimaternalchildhealthstudyinchina
AT pengxiaoqing cohortprofileanhuimaternalchildhealthstudyinchina
AT xuxiaofeng cohortprofileanhuimaternalchildhealthstudyinchina
AT zhouweiju cohortprofileanhuimaternalchildhealthstudyinchina
AT khutanranjit cohortprofileanhuimaternalchildhealthstudyinchina
AT taofangbiao cohortprofileanhuimaternalchildhealthstudyinchina
AT chenruoling cohortprofileanhuimaternalchildhealthstudyinchina